XPH
XPH
About State Street SPDR S&P Pharmaceuticals ETF
The State Street SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index (the "Index")Seeks to provide exposure to the pharmaceuticals segment of the S&P TMI, which comprises the Pharmaceuticals sub-industrySeeks to track a modified equal weighted index...
About State Street SPDR S&P Pharmaceuticals ETF
The State Street SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index (the "Index")Seeks to provide exposure to the pharmaceuticals segment of the S&P TMI, which comprises the Pharmaceuticals sub-industrySeeks to track a modified equal weighted index...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 DFTX | Definium Therapeutics, Inc. | 2.55% | 490.01K | $8.47M |
 VTRS | Viatris Inc. | 2.40% | 522.96K | $7.98M |
 PAHC | Phibro Animal Health Corporation | 2.33% | 141.12K | $7.72M |
 EWTX | Edgewise Therapeutics, Inc. | 2.29% | 255.53K | $7.58M |
 ELAN | Elanco Animal Health Incorporated | 2.25% | 284.80K | $7.46M |
 MRK | Merck & Co., Inc. | 2.24% | 62.15K | $7.41M |
 MBX | MBX Biosciences, Inc. Common Stock | 2.22% | 210.49K | $7.38M |
 SUPN | Supernus Pharmaceuticals, Inc. | 2.21% | 131.42K | $7.33M |
 BMY | Bristol-Myers Squibb Company | 2.18% | 118.46K | $7.24M |
 AMRX | Amneal Pharmaceuticals, Inc. | 2.17% | 496.83K | $7.20M |
 RPRX | Royalty Pharma plc | 2.17% | 158.56K | $7.19M |
 JNJ | Johnson & Johnson | 2.16% | 29.37K | $7.15M |
 AMLX | Amylyx Pharmaceuticals, Inc. | 2.11% | 458.53K | $7.00M |
 JAZZ | Jazz Pharmaceuticals plc | 2.10% | 36.77K | $6.95M |
 PBH | Prestige Consumer Healthcare Inc. | 2.09% | 98.86K | $6.94M |
 INVA | Innoviva, Inc. | 2.09% | 294.20K | $6.93M |
 NKTR | Nektar Therapeutics | 2.09% | 105.06K | $6.92M |
 ELVN | Enliven Therapeutics, Inc. | 2.04% | 228.81K | $6.78M |
 ZTS | Zoetis Inc. | 2.01% | 51.38K | $6.67M |
 AXSM | Axsome Therapeutics, Inc. | 2.00% | 40.64K | $6.63M |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
Ireland
Singapore
Cayman IslandsSECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States Ireland Singapore Cayman IslandsHoldings (Top 20)
DFTX
Definium Therapeutics, Inc.
VTRS
Viatris Inc.
PAHC
Phibro Animal Health Corporation
EWTX
Edgewise Therapeutics, Inc.
ELAN
Elanco Animal Health Incorporated
MRK
Merck & Co., Inc.
MBX
MBX Biosciences, Inc. Common Stock
SUPN
Supernus Pharmaceuticals, Inc.
BMY
Bristol-Myers Squibb Company
AMRX
Amneal Pharmaceuticals, Inc.
RPRX
Royalty Pharma plc
JNJ
Johnson & Johnson
AMLX
Amylyx Pharmaceuticals, Inc.
JAZZ
Jazz Pharmaceuticals plc
PBH
Prestige Consumer Healthcare Inc.
INVA
Innoviva, Inc.
NKTR
Nektar Therapeutics
ELVN
Enliven Therapeutics, Inc.
ZTS
Zoetis Inc.
AXSM
Axsome Therapeutics, Inc.